| scholarly article | Q13442814 |
| P50 | author | Erwin G. Van Meir | Q30503507 |
| P2093 | author name string | M Tada | |
| N Ishii | |||
| D Maier | |||
| A Merlo | |||
| Y Sawamura | |||
| A C Diserens | |||
| P2860 | cites work | The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 |
| ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways | Q24321528 | ||
| P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 | Q28266637 | ||
| Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest | Q28270478 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF | Q29619663 | ||
| A simple p53 functional assay for screening cell lines, blood, and tumors | Q34397902 | ||
| Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. | Q35960464 | ||
| Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain | Q36818855 | ||
| Genetic alterations associated with the evolution and progression of astrocytic brain tumours | Q40427187 | ||
| Field cancerisation and polyclonal p53 mutation in the upper aero- digestive tract | Q54953383 | ||
| Frequent loss of the cyclin-dependent kinase-4 inhibitor gene in human gliomas. | Q55021597 | ||
| PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. | Q55477977 | ||
| Hemizygous or homozygous deletion of the chromosomal region containing the p16INK4a gene is associated with amplification of the EGF receptor gene in glioblastomas. | Q55478215 | ||
| 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers | Q55480673 | ||
| Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus | Q57269211 | ||
| Genetic instability leads to loss of both p53 alleles in a human glioblastoma | Q41064852 | ||
| p53 protein accumulation and gene mutations in human glioma cell lines | Q41509767 | ||
| Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro | Q41706700 | ||
| Establishment and characterization of five cell lines derived from human malignant gliomas | Q42817353 | ||
| Constitutional p53 mutations associated with brain tumors in young adults | Q46575531 | ||
| PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas | Q47740646 | ||
| Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas | Q47775705 | ||
| Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay | Q47975834 | ||
| PTEN mutations in gliomas and glioneuronal tumors. | Q47995275 | ||
| Subsets of glioblastoma multiforme defined by molecular genetic analysis | Q48379049 | ||
| Intrinsic brain-stem tumors of childhood: surgical indications | Q48391525 | ||
| Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay | Q48960481 | ||
| Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas | Q48972634 | ||
| P4510 | describes a project that uses | U-87MG ATCC | Q7863603 |
| LN-340 | Q54902777 | ||
| LN-382T | Q54902779 | ||
| LN-401 | Q54902780 | ||
| LN-405 | Q54902781 | ||
| LN-427 | Q54902782 | ||
| LN-428 | Q54902783 | ||
| LN-443 | Q54902784 | ||
| LN-444 | Q54902785 | ||
| LN-464 | Q54902786 | ||
| LN-71 | Q54902788 | ||
| LN-751 | Q54902789 | ||
| LN-827 | Q54902792 | ||
| LN-859 | Q54902793 | ||
| LN-992 | Q54902794 | ||
| SF188 | Q54952896 | ||
| SF763 | Q54952932 | ||
| SF767 | Q54952933 | ||
| U-118MG | Q54973503 | ||
| U-138MG | Q54973513 | ||
| U-178MG | Q54973519 | ||
| U-251MG | Q54973550 | ||
| U-343MG | Q54973568 | ||
| U-373MG ATCC | Q54973575 | ||
| T98G | Q52609889 | ||
| A-172 | Q54605968 | ||
| D-247MG | Q54817124 | ||
| Hs 683 | Q54895882 | ||
| LN-18 | Q54902768 | ||
| LN-215 | Q54902769 | ||
| LN-229 | Q54902771 | ||
| LN-235 | Q54902773 | ||
| LN-308 | Q54902775 | ||
| LN-319 | Q54902776 | ||
| P433 | issue | 3 | |
| P921 | main subject | cell line | Q21014462 |
| P304 | page(s) | 469-479 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Brain Pathology | Q4955776 |
| P1476 | title | Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines | |
| P478 | volume | 9 |
| Q54605968 | A-172 |
| Q54817124 | D-247MG |
| Q54895882 | Hs 683 |
| Q54902768 | LN-18 |
| Q54902769 | LN-215 |
| Q54902771 | LN-229 |
| Q54902773 | LN-235 |
| Q54902775 | LN-308 |
| Q54902776 | LN-319 |
| Q54902777 | LN-340 |
| Q54902779 | LN-382T |
| Q54902780 | LN-401 |
| Q54902781 | LN-405 |
| Q54902782 | LN-427 |
| Q54902783 | LN-428 |
| Q54902784 | LN-443 |
| Q54902785 | LN-444 |
| Q54902786 | LN-464 |
| Q54902788 | LN-71 |
| Q54902789 | LN-751 |
| Q54902792 | LN-827 |
| Q54902793 | LN-859 |
| Q54902794 | LN-992 |
| Q54952896 | SF188 |
| Q54952932 | SF763 |
| Q54952933 | SF767 |
| Q52609889 | T98G |
| Q54973503 | U-118MG |
| Q54973513 | U-138MG |
| Q54973519 | U-178MG |
| Q54973550 | U-251MG |
| Q54973568 | U-343MG |
| Q54973575 | U-373MG ATCC |
| Q7863603 | U-87MG ATCC |
| Q35677134 | A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy |
| Q30501296 | A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells |
| Q38954633 | A critical overview of long non-coding RNA in glioma etiology 2016: an update |
| Q27324733 | A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma |
| Q34568957 | A mosaic mouse model of astrocytoma identifies alphavbeta8 integrin as a negative regulator of tumor angiogenesis |
| Q39320231 | A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny |
| Q38741033 | A novel cell-permeable RDP-p53 fusion protein for specific inhibition on the growth of cancerous neural cells |
| Q48340796 | A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy |
| Q37492151 | A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1. |
| Q33112696 | A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1. |
| Q55397197 | A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells. |
| Q39236559 | ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells |
| Q43098841 | ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells. |
| Q90641009 | AEBP1 down regulation induced cell death pathway depends on PTEN status of glioma cells |
| Q58727164 | ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner |
| Q35103214 | Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma |
| Q57161414 | Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma |
| Q39895365 | Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in - vitro. |
| Q35847030 | Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways |
| Q35570177 | Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans |
| Q43600431 | Activation of extracellular-regulated kinases by normal and mutant EGF receptors |
| Q24555121 | Activation of the human PAX6 gene through the exon 1 enhancer by transcription factors SEF and Sp1 |
| Q34365378 | Active ras triggers death in glioblastoma cells through hyperstimulation of macropinocytosis |
| Q39680687 | Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity |
| Q40511785 | Alkylphosphocholine-induced glioma cell death is BCL-X(L)-sensitive, caspase-independent and characterized by massive cytoplasmic vacuole formation |
| Q48307341 | Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells |
| Q30417011 | Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch |
| Q27683806 | An improved monomeric infrared fluorescent protein for neuronal and tumour brain imaging |
| Q40722521 | Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. |
| Q46024830 | Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death. |
| Q42170315 | Antiproliferative effects of Tubi-bee propolis in glioblastoma cell lines |
| Q39095859 | Apoptosis-related gene expression in glioblastoma (LN-18) and medulloblastoma (Daoy) cell lines |
| Q46409357 | Are 25 SNPs from the CARDIoGRAM study associated with ischaemic stroke? |
| Q64107495 | Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide? |
| Q34667252 | Arsenite induces premature senescence via p53/p21 pathway as a result of DNA damage in human malignant glioblastoma cells |
| Q39290679 | Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP. |
| Q37625457 | Autophagy and oxidative stress in gliomas with IDH1 mutations |
| Q39421577 | Bay846, a new irreversible small molecule inhibitor of EGFR and Her2, is highly effective against malignant brain tumor models |
| Q34293024 | Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types |
| Q38943486 | Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization. |
| Q33598840 | Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage |
| Q49516500 | Bioinformatical analysis of gene expression signatures of different glioma subtypes |
| Q24684369 | Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression |
| Q42378296 | Brain lipid-binding protein promotes proliferation and modulates cell cycle in C6 rat glioma cells |
| Q64239669 | CHNO and Its Combination with Scutellarin Suppress the Proliferation and Induce the Apoptosis of Human Glioma Cells via Upregulation of Fas-Associated Factor 1 Expression |
| Q40616862 | CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death |
| Q33680449 | Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation |
| Q40749203 | Caveolin-1 expression is maintained in rat and human astroglioma cell lines |
| Q39700144 | Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signaling |
| Q39977339 | Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. |
| Q39712685 | Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent |
| Q42168743 | Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro |
| Q39064313 | Cisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells. |
| Q34037067 | Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres. |
| Q46232869 | Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. |
| Q58889406 | Cold atmospheric plasma treatment of melanoma and glioblastoma cancer cells |
| Q21133610 | Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model |
| Q34069663 | Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development |
| Q90629577 | Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity |
| Q37268884 | Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions |
| Q42222863 | Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entry |
| Q61449553 | Correlated MRI and Ultramicroscopy (MR-UM) of Brain Tumors Reveals Vast Heterogeneity of Tumor Infiltration and Neoangiogenesis in Preclinical Models and Human Disease |
| Q34198939 | Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model |
| Q36010078 | DNA fingerprinting of glioma cell lines and considerations on similarity measurements. |
| Q44083581 | DNA hypermethylation status of multiple genes in prostate adenocarcinomas |
| Q34994888 | Death pathways triggered by activated Ras in cancer cells |
| Q38784169 | Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers |
| Q34603835 | Deltex-1 activates mitotic signaling and proliferation and increases the clonogenic and invasive potential of U373 and LN18 glioblastoma cells and correlates with patient survival |
| Q39646942 | Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter |
| Q35869307 | Development of monoclonal antibodies to human microsomal epoxide hydrolase and analysis of "preneoplastic antigen"-like molecules |
| Q33611551 | Different molecular patterns in glioblastoma multiforme subtypes upon recurrence |
| Q60919667 | Differential Exosomic Proteomic Patterns and Their Influence in Resveratrol Sensitivities of Glioblastoma Cells |
| Q35748846 | Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations |
| Q35587229 | Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas |
| Q40237643 | Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines |
| Q44925953 | Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53. |
| Q40086566 | Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death |
| Q35061682 | Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cells |
| Q36682802 | Dual effect of serum amyloid A on the invasiveness of glioma cells. |
| Q46131414 | Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation |
| Q38725917 | E2F transcription factors associated with up-regulated genes in glioblastoma |
| Q36355848 | EGFR blockade prevents glioma escape from BRAFV600E targeted therapy |
| Q37445712 | EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180. |
| Q39953614 | Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells |
| Q47154528 | Engineering PTEN-L for Cell-Mediated Delivery. |
| Q40645479 | Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. |
| Q34395707 | Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies |
| Q35845255 | Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation |
| Q38708860 | Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients |
| Q92783224 | Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity |
| Q55474355 | Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2. |
| Q36361068 | Fermented mistletoe extract as a multimodal antitumoral agent in gliomas |
| Q38753773 | Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma. |
| Q35800503 | Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy |
| Q39991463 | Frequent and variable abnormalities in p14 tumor suppressor gene in glioma cell lines |
| Q33289143 | GAPDH is not regulated in human glioblastoma under hypoxic conditions |
| Q36089874 | GSK1838705A, an IGF-1R inhibitor, inhibits glioma cell proliferation and suppresses tumor growth in vivo |
| Q28476300 | GSK3beta regulates differentiation and growth arrest in glioblastoma |
| Q35198623 | Gamma-tocotrienol and hydroxy-chavicol synergistically inhibits growth and induces apoptosis of human glioma cells. |
| Q40060078 | Gene Delivery in Neuro-Oncology |
| Q35143797 | Genes and pathways driving glioblastomas in humans and murine disease models |
| Q36021580 | Genetic and hypoxic regulation of angiogenesis in gliomas |
| Q37602543 | Glioblastoma Multiforme Oncogenomics and Signaling Pathways |
| Q31885912 | Glioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damage |
| Q33317073 | Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines |
| Q33378368 | Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro. |
| Q30318543 | HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression |
| Q92356851 | HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells |
| Q34581562 | HSP90 regulates DNA repair via the interaction between XRCC1 and DNA polymerase β |
| Q35670756 | Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis |
| Q55242072 | Hierarchical closeness-based properties reveal cancer survivability and biomarker genes in molecular signaling networks. |
| Q47172701 | High-molecular-weight tropomyosins localize to the contractile rings of dividing CNS cells but are absent from malignant pediatric and adult CNS tumors |
| Q28190953 | Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5 |
| Q34052754 | Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma |
| Q24633377 | Human glioma growth is controlled by microRNA-10b |
| Q40577599 | Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas |
| Q43918452 | Hyperploidy induced by drugs that inhibit formation of microtubule promotes chromosome instability |
| Q53890346 | INK4a/Arf is required for suppression of EGFR/DeltaEGFR(2-7)-dependent ERK activation in mouse astrocytes and glioma. |
| Q38886482 | Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis |
| Q45398491 | Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells |
| Q33574853 | Immunocompetent murine models for the study of glioblastoma immunotherapy |
| Q46727514 | Inactivation of p53 sensitizes astrocytic glioma cells to BCNU and temozolomide, but not cisplatin |
| Q34365365 | Induction of nonapoptotic cell death by activated Ras requires inverse regulation of Rac1 and Arf6 |
| Q38970906 | Inhibition of HDAC increases the senescence induced by natural polyphenols in glioma cells |
| Q38323649 | Inhibition of N-Myc down regulated gene 1 in in vitro cultured human glioblastoma cells. |
| Q37022290 | Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo |
| Q54979176 | Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs. |
| Q36344771 | Integrative functional genomics identifies RINT1 as a novel GBM oncogene |
| Q33719798 | Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship |
| Q37179323 | Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma |
| Q38840489 | Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics |
| Q45539872 | JC virus early protein detection by immunohistochemistry in progressive multifocal leukoencephalopathy: a comparative study with in situ hybridization and polymerase chain reaction. |
| Q26859017 | Keep-ING balance: tumor suppression by epigenetic regulation |
| Q64078949 | Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide |
| Q36192530 | Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death |
| Q41967160 | Late ROS accumulation and radiosensitivity in SOD1-overexpressing human glioma cells |
| Q38398188 | Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor |
| Q24297357 | Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation |
| Q38991458 | Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival |
| Q39266398 | Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness |
| Q39354544 | LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells. |
| Q37130116 | MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma |
| Q28552962 | MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme |
| Q92912403 | MET in glioma: signaling pathways and targeted therapies |
| Q46296960 | Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death |
| Q39370401 | Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme |
| Q34318242 | Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide |
| Q37376084 | Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo |
| Q90084125 | Methionine metabolism in health and cancer: a nexus of diet and precision medicine |
| Q39308847 | Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide |
| Q35036059 | MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development |
| Q24336898 | MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators |
| Q35017058 | MicroRNA-19a promotes glioma cell growth by repressing LRIG1 |
| Q48397147 | Microtubule actin cross-linking factor 1, a novel target in glioblastoma. |
| Q92240775 | Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice |
| Q47325193 | Mitochondrial energy metabolism and signalling in human glioblastoma cell lines with different PTEN gene status |
| Q39097617 | Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line |
| Q34480160 | Molecular biology of nervous system tumors |
| Q47738114 | Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data |
| Q33716257 | Multiparameter computational modeling of tumor invasion |
| Q39012877 | Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384. |
| Q34977358 | N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide |
| Q35599399 | NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma |
| Q39304886 | Necrosis is not induced by gadolinium neutron capture in glioblastoma multiforme cells |
| Q36825579 | Network and pathway analysis of microRNAs, transcription factors, target genes and host genes in human glioma |
| Q36004162 | New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer |
| Q89989620 | New drugs are not enough‑drug repositioning in oncology: An update |
| Q36635311 | Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation. |
| Q41675187 | Nutlin-3a Nanodisks Induce p53 Stabilization and Apoptosis in a Subset of Cultured Glioblastoma Cells |
| Q35844142 | O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies |
| Q64238496 | On the influence of cannabinoids on cell morphology and motility of glioblastoma cells |
| Q42935268 | Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway |
| Q34802264 | Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair |
| Q35858003 | P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3. |
| Q41864823 | P14ARF suppresses tumor-induced thrombosis by regulating the tissue factor pathway. |
| Q40453259 | PAX6 suppresses growth of human glioblastoma cells. |
| Q33599207 | PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A |
| Q40453267 | PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas. |
| Q37719276 | PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors |
| Q30416701 | PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations |
| Q35070903 | PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity |
| Q35661819 | PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. |
| Q33958963 | PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors. |
| Q37207668 | PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1. |
| Q35092641 | PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation |
| Q24303571 | PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling |
| Q77361286 | Persistent use of misidentified cell lines and its prevention |
| Q27851556 | Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts |
| Q48464361 | Pharmacologic manipulations of mitochondrial membrane potential (DeltaPsim) selectively in glioma cells |
| Q38985518 | Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro |
| Q34886884 | Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival. |
| Q90145933 | Plasmonic gold nanostar-mediated photothermal immunotherapy for brain tumor ablation and immunologic memory |
| Q59132119 | Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide |
| Q55470737 | Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling. |
| Q38208182 | Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas |
| Q55474425 | Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas. |
| Q39689666 | ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro |
| Q39874006 | Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines |
| Q93049221 | Radiosensitization and a Less Aggressive Phenotype of Human Malignant Glioma Cells Expressing Isocitrate Dehydrogenase 1 (IDH1) Mutant Protein: Dissecting the Mechanisms |
| Q61794392 | Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma |
| Q34739540 | Regulation of glioblastoma cell invasion by PKC iota and RhoB. |
| Q39905965 | Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. |
| Q39436597 | Repression of cancer cell senescence by PKCι. |
| Q40185681 | Repression of p53-mediated transcription by adenovirus E1B 55-kDa does not require corepressor mSin3A and histone deacetylases |
| Q39954297 | Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins |
| Q36212896 | Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240. |
| Q33644048 | Restoration of endogenous wild-type p53 activity in a glioblastoma cell line with intrinsic temperature-sensitive p53 induces growth arrest but not apoptosis |
| Q28750173 | Retracted: Differential SELEX in Human Glioma Cell Lines |
| Q92966660 | Rodent Glioma Models: Intracranial Stereotactic Allografts and Xenografts |
| Q41917289 | SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans |
| Q38903930 | STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma. |
| Q34277050 | Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription |
| Q90062681 | Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment |
| Q48939509 | Second primary glioblastoma |
| Q42370561 | Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy |
| Q39334108 | Silencing of Eps8 blocks migration and invasion in human glioblastoma cell lines |
| Q35176325 | Silencing of the tumor suppressor gene WNK2 is associated with upregulation of MMP2 and JNK in gliomas |
| Q37269355 | Small-molecule XIAP inhibitors enhance gamma-irradiation-induced apoptosis in glioblastoma |
| Q34269290 | Stemness of the CT-2A Immunocompetent Mouse Brain Tumor Model: Characterization In Vitro |
| Q30391301 | Structural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancer |
| Q28833679 | Structure-activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway [...] |
| Q26850467 | Sui generis: gene therapy and delivery systems for the treatment of glioblastoma |
| Q33989679 | Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors |
| Q35683150 | Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth |
| Q34159322 | Synthesis and evaluation of indole-based chalcones as inducers of methuosis, a novel type of nonapoptotic cell death |
| Q64244322 | Synthetic Cannabinoids Influence the Invasion of Glioblastoma Cell Lines in a Cell- and Receptor-Dependent Manner |
| Q36546689 | TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo |
| Q35756919 | TRAIL and malignant glioma. |
| Q92541976 | TRPM7 Induces Mechanistic Target of Rap1b Through the Downregulation of miR-28-5p in Glioma Proliferation and Invasion |
| Q36488714 | Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4 |
| Q37041337 | Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression |
| Q27652488 | Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases |
| Q33780536 | Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential |
| Q39740608 | Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma |
| Q38697698 | Temozolomide induces autophagy in primary and established glioblastoma cells in an EGFR independent manner |
| Q39214188 | Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells |
| Q39627791 | The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma |
| Q40862061 | The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme |
| Q34064643 | The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival |
| Q61447495 | The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma |
| Q35085317 | The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence |
| Q40782828 | The development of necrosis and apoptosis in glioma: experimental findings using spheroid culture systems |
| Q35105214 | The effect of photoinitiators on intracellular AKT signaling pathway in tissue engineering application |
| Q38990450 | The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells. |
| Q28391635 | The future role of personalized medicine in the treatment of glioblastoma multiforme |
| Q64052634 | The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells |
| Q46504176 | The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha ) and inhibits HIF-1-mediated transcription |
| Q57162865 | The p53 Pathway in Glioblastoma |
| Q35296657 | The polyamine catabolic enzyme SAT1 modulates tumorigenesis and radiation response in GBM |
| Q34480697 | The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells |
| Q39820505 | The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair. |
| Q48362692 | The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells |
| Q38742530 | Therapeutic Hypothesis Testing With Rodent Brain Tumor Models. |
| Q37137412 | Therapeutic approaches to target cancer stem cells |
| Q39691784 | Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma |
| Q59134245 | Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells |
| Q36368481 | Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells |
| Q38956529 | Tocotrienol-rich fraction, [6]-gingerol and epigallocatechin gallate inhibit proliferation and induce apoptosis of glioma cancer cells. |
| Q61812918 | Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway |
| Q50083504 | Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas. |
| Q35000404 | U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells |
| Q36782143 | Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy. |
| Q33112684 | Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism |
| Q42974434 | Vorinostat(SAHA) Promotes Hyper-Radiosensitivity in Wild Type p53 Human Glioblastoma Cells. |
| Q38899864 | WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. |
| Q38043443 | What We Know about the Molecular Genetics of Central Nervous System (CNS) Tumours in Malaysia |
| Q35751162 | Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression |
| Q39209883 | ZFX regulates glioma cell proliferation and survival in vitro and in vivo |
| Q34423084 | miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas |
| Q28307352 | miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors |
| Q36048184 | p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells |
| Q37522828 | p53 isoform profiling in glioblastoma and injured brain |
Search more.